Antitumoral efficacy of DNA nanoparticles in murine models of lung cancer and pulmonary metastasis (Q45886686)

17 December 2017

title

Antitumoral efficacy of DNA nanoparticles in murine models of lung cancer and pulmonary metastasis (English)

1 reference

17 December 2017

0 references

4

1 reference

17 December 2017

author name string

M Rodrigo-Garzón

1

1 reference

17 December 2017

P Berraondo

2

1 reference

17 December 2017

L Ochoa

3

1 reference

17 December 2017

G González-Aseguinolaza

5

1 reference

17 December 2017

publication date

1 January 2010

1 reference

17 December 2017

published in

Cancer Gene Therapy

1 reference

17 December 2017

volume

17

1 reference

17 December 2017

issue

1

1 reference

17 December 2017

page(s)

20-27

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/cgt.2009.45

exact match

0 references

cites work

Update in lung cancer 2007

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Cancer burden in the year 2000. The global picture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Interleukin-12 and the regulation of innate resistance and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Antitumor and antimetastatic activity of interleukin 12 against murine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

IL-12 treatment of endogenously arising murine brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Phase II study of intraperitoneal recombinant interleukin-12 (rhIL-12) in patients with peritoneal carcinomatosis (residual disease < 1 cm) associated with ovarian cancer or primary peritoneal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Gene therapy for lung cancer and mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Gene therapy for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Intranasal interleukin-12 gene therapy enhanced the activity of ifosfamide against osteosarcoma lung metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Gene therapy of cancer based on interleukin 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

In vivo delivery to tumors of DNA complexed with linear polyethylenimine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Ovarian carcinoma cells are effectively transfected by polyethylenimine (PEI) derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

ELISPOT assay to measure antigen-specific murine CD8(+) T cell responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Intrahepatic injection of recombinant adeno-associated virus serotype 2 overcomes gender-related differences in liver transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Toll-like receptor 9-dependent immune activation by unmethylated CpG motifs in Aspergillus fumigatus DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Direct immunologic activities of CpG DNA and implications for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Intravenous cytokine gene delivery by lipid-DNA complexes controls the growth of established lung metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Systemic administration of LPD prepared with CpG oligonucleotides inhibits the growth of established pulmonary metastases by stimulating innate and acquired antitumor immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Induction of gp120-specific protective immune responses by genetic vaccination with linear polyethylenimine-plasmid complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Improving efficacy of interleukin-12-transfected dendritic cells injected into murine colon cancer with anti-CD137 monoclonal antibodies and alloantigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Randomized phase II study of interleukin-12 in combination with rituximab in previously treated non-Hodgkin's lymphoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

7 January 2021

Immune modulation as a therapeutic strategy for non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

7 January 2021

p53 aerosol formulation with low toxicity and high efficiency for early lung cancer treatment

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

7 January 2021

Bacterial DNA-induced NK cell IFN-gamma production is dependent on macrophage secretion of IL-12

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

7 January 2021

Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

7 January 2021

The inhibitory role of CpG immunostimulatory motifs in cationic lipid vector-mediated transgene expression in vivo

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

7 January 2021

Identifiers

DOI

10.1038/CGT.2009.45

1 reference

17 December 2017

Dimensions Publication ID

0 references

1 reference

17 December 2017